• Consensus Rating: Moderate Buy
  • Consensus Price Target: $92.59
  • Forecasted Upside: 23.29%
  • Number of Analysts: 14
  • Breakdown:
  • 0 Sell Ratings
  • 3 Hold Ratings
  • 11 Buy Ratings
  • 0 Strong Buy Ratings
▲ +1.09 (1.47%)

This chart shows the closing price for CVS by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New CVS Health Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CVS and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CVS

Analyst Price Target is $92.59
▲ +23.29% Upside Potential
This price target is based on 14 analysts offering 12 month price targets for CVS Health in the last 3 months. The average price target is $92.59, with a high forecast of $143.00 and a low forecast of $76.00. The average price target represents a 23.29% upside from the last price of $75.10.

This chart shows the closing price for CVS for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Moderate Buy

The current consensus among 14 contributing investment analysts is to moderate buy stock in CVS Health. This Moderate Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 11 buy ratings
  • 3 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 11 buy ratings
  • 3 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 11 buy ratings
  • 3 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 11 buy ratings
  • 3 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 11 buy ratings
  • 3 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 11 buy ratings
  • 3 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 11 buy ratings
  • 3 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 11 buy ratings
  • 3 hold ratings
  • 0 sell ratings

Latest Recommendations

  • 0 strong buy ratings
  • 11 buy ratings
  • 3 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/21/2023Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$87.00Low
11/2/2023Morgan StanleyLower TargetOverweight ➝ Overweight$110.00 ➝ $100.00N/A
11/2/2023Royal Bank of CanadaLower TargetOutperform ➝ Outperform$91.00 ➝ $86.00N/A
10/10/2023Sanford C. BernsteinLower Target$93.00 ➝ $80.00Low
9/19/2023Evercore ISIUpgradeIn-Line ➝ Outperform$81.00 ➝ $83.00Low
9/14/2023Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$87.00Low
9/12/2023Wolfe ResearchUpgradePeer Perform ➝ Outperform$80.00Low
9/1/2023Piper SandlerLower TargetOverweight ➝ Overweight$85.00 ➝ $82.00Low
8/18/2023Royal Bank of CanadaReiterated RatingOutperform ➝ Outperform$91.00Low
8/17/2023Edward JonesDowngradeBuy ➝ HoldLow
8/4/2023Raymond JamesLower TargetOutperform ➝ Outperform$90.00 ➝ $85.00Low
8/3/2023Morgan StanleyLower TargetOverweight ➝ Overweight$120.00 ➝ $110.00Low
8/3/2023Royal Bank of CanadaLower TargetOutperform ➝ Outperform$102.00 ➝ $91.00Low
8/3/2023Truist FinancialLower TargetBuy ➝ Buy$103.00 ➝ $98.00Low
8/3/2023BarclaysLower TargetOverweight ➝ Overweight$89.00 ➝ $86.00Low
7/12/2023BarclaysLower Target$90.00 ➝ $89.00Low
7/11/2023MizuhoLower Target$120.00 ➝ $88.00Low
7/7/2023JPMorgan Chase & Co.Lower Target$114.00 ➝ $106.00Low
6/20/2023Truist FinancialLower Target$109.00 ➝ $103.00Low
5/30/2023JPMorgan Chase & Co.Lower Target$125.00 ➝ $114.00Low
5/25/2023Piper SandlerInitiated CoverageOverweight$85.00Low
5/8/2023Wells Fargo & CompanyLower Target$95.00 ➝ $76.00Low
5/8/2023Credit Suisse GroupLower Target$125.00 ➝ $96.00Low
5/4/2023Truist FinancialLower Target$115.00 ➝ $109.00Low
5/4/2023BarclaysLower Target$100.00 ➝ $90.00Low
5/2/2023UBS GroupLower Target$102.00 ➝ $94.00Low
5/2/2023Sanford C. BernsteinLower Target$107.00 ➝ $93.00Low
4/20/2023Cantor FitzgeraldInitiated CoverageOverweight$87.00Low
4/10/2023Deutsche Bank AktiengesellschaftInitiated CoverageHoldLow
3/31/2023Bank of AmericaLower TargetBuy$111.00 ➝ $104.00Low
3/30/2023BarclaysLower TargetOverweight$110.00 ➝ $100.00Low
2/9/2023Royal Bank of CanadaReiterated RatingOutperform$115.00Low
2/9/2023Jefferies Financial GroupBoost TargetBuy$130.00 ➝ $143.00Low
2/9/2023Raymond JamesLower TargetOutperform$115.00 ➝ $110.00Low
2/9/2023BarclaysLower TargetOverweight$118.00 ➝ $110.00Low
1/13/2023Morgan StanleyBoost TargetOverweight$119.00 ➝ $120.00Low
1/3/2023Wells Fargo & CompanyLower TargetEqual Weight$106.00 ➝ $101.00Low
11/23/2022Morgan StanleyLower TargetOverweight$124.00 ➝ $119.00Low
11/21/2022Credit Suisse GroupBoost TargetOutperform$117.00 ➝ $125.00Low
11/8/2022Wells Fargo & CompanyLower TargetEqual Weight$111.00 ➝ $106.00Low
11/7/2022Royal Bank of CanadaLower TargetOutperform$119.00 ➝ $115.00Low
11/6/2022Raymond JamesLower Target$120.00 ➝ $115.00Low
11/3/2022JPMorgan Chase & Co.Lower TargetOverweight$130.00 ➝ $125.00Low
11/3/2022The Goldman Sachs GroupLower TargetBuy$128.00 ➝ $113.00Low
10/20/2022Bank of AmericaLower TargetBuy$122.00 ➝ $118.00Low
10/11/2022Morgan StanleyLower TargetOverweight$127.00 ➝ $124.00Low
9/7/2022Evercore ISIBoost TargetOutperform$120.00 ➝ $125.00Low
8/17/2022Tigress FinancialBoost Target$125.00 ➝ $130.00Low
8/15/2022MizuhoBoost TargetBuy$115.00 ➝ $120.00Low
8/8/2022Credit Suisse GroupBoost TargetOutperform$113.00 ➝ $117.00Low
8/4/2022UBS GroupBoost TargetBuy$118.00 ➝ $127.00Low
8/4/2022Deutsche Bank AktiengesellschaftBoost Target$113.00 ➝ $120.00Low
6/16/2022Loop CapitalInitiated CoverageBuy$120.00Medium
5/26/2022Sanford C. BernsteinDowngradeOutperform ➝ Market Perform$122.00 ➝ $112.00Medium
5/5/2022Deutsche Bank AktiengesellschaftBoost Target$110.00 ➝ $113.00High
4/7/2022Tigress FinancialBoost Target$122.00 ➝ $125.00Low
3/29/2022Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold$110.00High
2/17/2022Deutsche Bank AktiengesellschaftBoost Target$107.00 ➝ $110.00Medium
2/11/2022Raymond JamesDowngradeStrong-Buy ➝ Outperform$115.00 ➝ $120.00High
2/10/2022BMO Capital MarketsBoost Target$108.00 ➝ $120.00Medium
1/12/2022Robert W. BairdBoost Target$107.00 ➝ $110.00Low
1/11/2022Sanford C. BernsteinBoost Target$111.00 ➝ $116.00Low
1/10/2022Edward JonesUpgradeHold ➝ BuyMedium
1/5/2022Truist FinancialBoost TargetBuy ➝ Buy$118.00 ➝ $124.00Low
12/23/2021Tigress FinancialBoost TargetBuy$108.00 ➝ $122.00Low
12/20/2021MizuhoBoost TargetBuy$110.00 ➝ $115.00Low
12/14/2021Robert W. BairdReiterated RatingHoldLow
12/14/2021The Goldman Sachs GroupInitiated CoverageBuy$121.00Low
12/13/2021Morgan StanleyBoost TargetOverweight ➝ Overweight$115.00 ➝ $125.00Low
12/13/2021Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$98.00 ➝ $107.00Low
12/13/2021Robert W. BairdBoost TargetNeutral ➝ Neutral$100.00 ➝ $107.00Low
12/10/2021Truist FinancialBoost TargetBuy ➝ Buy$112.00 ➝ $118.00Low
12/10/2021CowenBoost TargetOutperform ➝ Outperform$103.00 ➝ $114.00Low
12/10/2021Royal Bank of CanadaBoost TargetOutperform ➝ Outperform$107.00 ➝ $119.00Medium
12/10/2021Credit Suisse GroupBoost TargetOutperform ➝ Outperform$107.00 ➝ $120.00Medium
12/10/2021MizuhoBoost TargetBuy ➝ Buy$105.00 ➝ $110.00Medium
12/6/2021Morgan StanleyBoost TargetOverweight$114.00 ➝ $115.00Medium
12/1/2021Seaport Res PtnReiterated RatingBuyMedium
11/10/2021MizuhoBoost TargetBuy$98.00 ➝ $105.00Low
11/5/2021Deutsche Bank AktiengesellschaftBoost TargetBuy$101.00 ➝ $107.00Medium
11/5/2021Credit Suisse GroupBoost TargetOutperform$100.00 ➝ $107.00Low
11/5/2021JPMorgan Chase & Co.Boost TargetBuy ➝ Overweight$107.00 ➝ $115.00Low
11/4/2021Truist FinancialBoost TargetBuy$94.00 ➝ $112.00Medium
11/4/2021Royal Bank of CanadaBoost TargetOutperform$97.00 ➝ $107.00Medium
11/4/2021Raymond JamesBoost TargetStrong-Buy$95.00 ➝ $115.00Medium
11/4/2021CitigroupBoost TargetBuy$98.00 ➝ $111.00Medium
11/4/2021BarclaysBoost TargetOverweight$100.00 ➝ $110.00Medium
10/21/2021MizuhoReiterated RatingBuyMedium
8/31/2021Morgan StanleyBoost TargetTop Pick ➝ Overweight$99.00 ➝ $114.00High
8/5/2021Deutsche Bank AktiengesellschaftBoost TargetBuy$95.00 ➝ $101.00High
7/23/2021Tigress FinancialReiterated RatingBuy$108.00Low
6/22/2021Deutsche Bank AktiengesellschaftLower TargetBuy$99.00 ➝ $95.00Low
5/24/2021Wells Fargo & CompanyInitiated CoverageEqual Weight$89.00N/A
5/19/2021BMO Capital MarketsBoost TargetPositive ➝ Market Perform$90.00 ➝ $96.00High
5/19/2021BarclaysBoost TargetOverweight$92.00 ➝ $100.00High
5/19/2021Wolfe ResearchBoost TargetPositive ➝ Outperform$82.00 ➝ $93.00High
5/18/2021Wells Fargo & CompanyInitiated CoverageEqual Weight$89.00Medium
5/12/2021MizuhoBoost TargetPositive ➝ Buy$82.00 ➝ $98.00Low
5/6/2021Credit Suisse GroupBoost TargetOutperform$91.00 ➝ $100.00Low
5/6/2021BMO Capital MarketsBoost TargetMarket Perform$82.00 ➝ $90.00Low
5/5/2021CitigroupBoost Target$83.00 ➝ $98.00Medium
5/5/2021Jefferies Financial GroupBoost TargetBuy$90.00 ➝ $95.00Medium
5/5/2021Raymond JamesBoost TargetStrong-Buy$90.00 ➝ $95.00High
5/5/2021Royal Bank of CanadaBoost TargetOutperform$80.00 ➝ $91.00High
4/14/2021Truist FinancialBoost TargetBuy$80.00 ➝ $88.00Low
4/14/2021Morgan StanleyBoost TargetOverweight$86.00 ➝ $92.00Medium
3/23/2021GuggenheimReiterated RatingBuy ➝ NeutralMedium
3/17/2021GuggenheimDowngradeBuy ➝ NeutralLow
1/8/2021Jefferies Financial GroupUpgradeHold ➝ Buy$90.00Low
12/14/2020SVB LeerinkBoost TargetMarket Perform$73.00 ➝ $80.00High
11/11/2020Piper SandlerBoost TargetOverweight$72.00 ➝ $76.00Low
11/9/2020Cantor FitzgeraldReiterated RatingOverweightHigh
11/9/2020Deutsche Bank AktiengesellschaftLower TargetBuy$104.00 ➝ $101.00High
9/17/2020Piper SandlerInitiated CoverageOverweight$72.00 ➝ $72.00Medium
8/7/2020Credit Suisse GroupBoost TargetOutperform$75.00 ➝ $90.00Medium
8/6/2020Deutsche Bank AktiengesellschaftLower TargetBuy$109.00 ➝ $104.00Low
8/6/2020SVB LeerinkBoost TargetMarket Perform$72.00 ➝ $73.00Low
7/9/2020Royal Bank of CanadaReiterated RatingBuyLow
7/1/2020SVB LeerinkInitiated CoverageMarket Perform$72.00Low
5/14/2020Credit Suisse GroupUpgradeNeutral ➝ Outperform$75.00Low
5/8/2020Credit Suisse GroupReiterated RatingHoldLow
5/7/2020Robert W. BairdBoost TargetNeutral$62.00 ➝ $66.00Low
5/7/2020UBS GroupLower TargetBuy$85.00 ➝ $79.00Low
5/7/2020CitigroupLower TargetBuy$86.00 ➝ $75.00Low
5/7/2020Morgan StanleyBoost TargetOverweight$71.00 ➝ $77.00Low
5/6/2020Royal Bank of CanadaReiterated RatingBuy$77.00High
5/6/2020OppenheimerReiterated RatingHoldHigh
5/4/2020JPMorgan Chase & Co.Lower TargetOverweight$97.00 ➝ $94.00Low
4/24/2020Tigress FinancialReiterated RatingBuyMedium
4/13/2020Morgan StanleyBoost TargetOverweight$70.00 ➝ $71.00Low
4/13/2020SunTrust BanksLower TargetBuy$90.00 ➝ $80.00Medium
4/12/2020Royal Bank of CanadaReiterated RatingBuy$77.00High
3/27/2020Morgan StanleyLower TargetOverweight$88.00 ➝ $70.00Medium
3/27/2020Robert W. BairdLower TargetNeutral$73.00 ➝ $62.00Medium
3/25/2020Royal Bank of CanadaLower Target$85.00 ➝ $81.00Medium
3/19/2020Credit Suisse GroupReiterated RatingHold$75.00Medium
2/18/2020Deutsche Bank AktiengesellschaftBoost TargetBuy$97.00 ➝ $109.00Low
2/14/2020CitigroupBoost TargetBuy$83.00 ➝ $86.00Medium
2/13/2020Robert W. BairdBoost TargetNeutral$70.00 ➝ $73.00Medium
2/13/2020UBS GroupBoost TargetBuy$78.00 ➝ $85.00Medium
2/13/2020Cantor FitzgeraldBoost TargetOverweight$85.00 ➝ $90.00Medium
2/12/2020OppenheimerInitiated CoverageHoldMedium
2/12/2020CfraBoost TargetStrong-Buy$85.00 ➝ $86.00Medium
12/19/2019JPMorgan Chase & Co.Boost TargetOverweight$88.00 ➝ $97.00Low
12/4/2019Raymond JamesReiterated RatingStrong-Buy$80.00 ➝ $90.00Low
11/8/2019MizuhoBoost TargetBuy$71.00 ➝ $82.00Low
11/7/2019UBS GroupReiterated RatingBuy$78.00 ➝ $78.00Low
11/7/2019Raymond JamesBoost TargetStrong-Buy$75.00 ➝ $80.00Low
11/7/2019SunTrust BanksBoost TargetBuy$85.00Low
11/7/2019CitigroupBoost TargetBuy$72.00 ➝ $83.00Low
10/21/2019CowenSet TargetBuy$76.00Low
9/27/2019Royal Bank of CanadaInitiated CoverageOutperform$85.00Low
9/26/2019Morgan StanleyBoost TargetOverweight$74.00 ➝ $77.00Medium
9/12/2019Bank of AmericaBoost TargetBuy$72.00 ➝ $75.00Low
9/12/2019Deutsche Bank AktiengesellschaftInitiated CoverageBuy$91.00Medium
8/27/2019CowenReiterated RatingOutperform$69.00 ➝ $76.00Medium
8/11/2019Morgan StanleyReiterated RatingBuy$74.00Low
8/8/2019CitigroupBoost TargetBuy$68.00 ➝ $72.00Medium
8/7/2019Evercore ISISet TargetBuy$63.00Low
6/5/2019MizuhoSet TargetBuy$71.00Medium
6/5/2019Standpoint ResearchUpgradeHold ➝ BuyHigh
5/3/2019BMO Capital MarketsSet TargetHold$63.00Low
5/2/2019CitigroupSet TargetBuy$74.00Low
5/2/2019UBS GroupLower TargetSell ➝ Sell$74.00 ➝ $67.00Low
5/1/2019Cantor FitzgeraldReiterated RatingBuy$80.00Low
4/29/2019Morgan StanleyLower TargetOverweight ➝ Overweight$92.00 ➝ $74.00Low
4/29/2019Credit Suisse GroupDowngradeOutperform ➝ Neutral$73.00 ➝ $61.00Medium
4/21/2019Cantor FitzgeraldReiterated RatingBuy$80.00Low
4/18/2019Raymond JamesLower TargetStrong-Buy ➝ Strong-Buy$90.00 ➝ $75.00Low
4/18/2019GuggenheimInitiated CoverageBuy ➝ Buy$90.00 ➝ $75.00Low
4/15/2019CIBCReiterated RatingOutperform ➝ Market PerformLow
4/15/2019OppenheimerDowngradeOutperform ➝ Market PerformLow
4/11/2019BarclaysSet TargetBuy$73.00High
4/10/2019BMO Capital MarketsInitiated CoverageOutperform$58.00Medium
4/10/2019SunTrust BanksLower Target$85.00 ➝ $65.00Low
4/10/2019Bank of AmericaReiterated RatingBuy$82.00 ➝ $74.00Low
3/12/2019Sanford C. BernsteinInitiated CoverageOutperform ➝ Outperform$76.00High
3/6/2019CitigroupLower TargetBuy ➝ Buy$94.00 ➝ $68.00Medium
2/25/2019ArgusLower TargetBuy ➝ Positive$100.00 ➝ $80.00Low
2/22/2019Morgan StanleySet TargetBuy$92.00Low
2/21/2019SunTrust BanksLower TargetBuy$85.00Medium
2/21/2019UBS GroupLower TargetBuy ➝ Buy$75.00 ➝ $74.00High
2/21/2019Loop CapitalLower TargetIn-Line ➝ Hold$68.00High
2/21/2019JPMorgan Chase & Co.Reiterated RatingOverweight$91.00High
2/21/2019Cantor FitzgeraldReiterated RatingOverweight$80.00High
2/20/2019Wells Fargo & CompanyDowngradeOutperform ➝ Market Perform$104.00 ➝ $68.00High
1/17/2019UBS GroupInitiated CoverageBuy ➝ Buy$75.00Low
1/3/2019Cantor FitzgeraldReiterated RatingBuy$96.00Low
1/3/2019Bank of AmericaReiterated RatingBuy$92.00Low
12/18/2018BarclaysInitiated CoverageOverweight ➝ Overweight$91.00Medium
12/11/2018SVB LeerinkInitiated CoverageOutperformMedium
(Data available from 12/9/2018 forward)

News Sentiment Rating

0.58 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 25 very positive mentions
  • 50 positive mentions
  • 11 negative mentions
  • 6 very negative mentions
  • 12 very positive mentions
  • 29 positive mentions
  • 10 negative mentions
  • 1 very negative mentions
  • 35 very positive mentions
  • 31 positive mentions
  • 12 negative mentions
  • 8 very negative mentions
  • 31 very positive mentions
  • 49 positive mentions
  • 13 negative mentions
  • 0 very negative mentions
  • 26 very positive mentions
  • 50 positive mentions
  • 15 negative mentions
  • 5 very negative mentions
  • 41 very positive mentions
  • 49 positive mentions
  • 14 negative mentions
  • 8 very negative mentions
  • 31 very positive mentions
  • 52 positive mentions
  • 17 negative mentions
  • 5 very negative mentions
  • 36 very positive mentions
  • 48 positive mentions
  • 8 negative mentions
  • 4 very negative mentions

Current Sentiment

  • 36 very positive mentions
  • 48 positive mentions
  • 8 negative mentions
  • 4 very negative mentions

Recent Stories by Sentiment

CVS Health logo
CVS Health Corporation provides health services in the United States. It operates through Health Care Benefits, Pharmacy Services, and Retail/LTC segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail-order, mail-order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.
Read More

Today's Range

Now: $75.10
Low: $73.88
High: $75.52

50 Day Range

MA: $69.60
Low: $66.33
High: $75.10

52 Week Range

Now: $75.10
Low: $64.41
High: $104.83


10,232,693 shs

Average Volume

8,697,494 shs

Market Capitalization

$96.65 billion

P/E Ratio


Dividend Yield




Frequently Asked Questions

What sell-side analysts currently cover shares of CVS Health?

The following Wall Street analysts have issued stock ratings on CVS Health in the last twelve months: Bank of America Co., Barclays PLC, Cantor Fitzgerald, Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, Edward Jones, Evercore ISI, Jefferies Financial Group Inc., JPMorgan Chase & Co., Mizuho, Morgan Stanley, Piper Sandler, Raymond James, Royal Bank of Canada, Sanford C. Bernstein, StockNews.com, TheStreet, Truist Financial Co., UBS Group AG, Wells Fargo & Company, and Wolfe Research.
View the latest analyst ratings for CVS.

What is the current price target for CVS Health?

17 Wall Street analysts have set twelve-month price targets for CVS Health in the last year. Their average twelve-month price target is $92.59, suggesting a possible upside of 23.3%. Jefferies Financial Group Inc. has the highest price target set, predicting CVS will reach $143.00 in the next twelve months. Wells Fargo & Company has the lowest price target set, forecasting a price of $76.00 for CVS Health in the next year.
View the latest price targets for CVS.

What is the current consensus analyst rating for CVS Health?

CVS Health currently has 3 hold ratings and 11 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for CVS.

What other companies compete with CVS Health?

Other companies that are similar to CVS Health include MercadoLibre, Starbucks, Booking, Lowe's Companies and Target. Learn More about companies similar to CVS Health.

How do I contact CVS Health's investor relations team?

CVS Health's physical mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator's listed phone number is (401) 765-1500 and its investor relations email address is [email protected]. The official website for CVS Health is www.cvshealth.com. Learn More about contacing CVS Health investor relations.